These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Changes in serum inflammatory markers are associated with changes in apolipoprotein A1 but not B after the initiation of dialysis. Kaysen GA; Dalrymple LS; Grimes B; Chertow GM; Kornak J; Johansen KL Nephrol Dial Transplant; 2014 Feb; 29(2):430-7. PubMed ID: 24009290 [TBL] [Abstract][Full Text] [Related]
24. Very small apolipoprotein A-I-containing particles from human plasma: isolation and quantification by high-performance size-exclusion chromatography. Nanjee MN; Brinton EA Clin Chem; 2000 Feb; 46(2):207-23. PubMed ID: 10657377 [TBL] [Abstract][Full Text] [Related]
25. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease. Genest JJ; Bard JM; Fruchart JC; Ordovas JM; Wilson PF; Schaefer EJ Atherosclerosis; 1991 Oct; 90(2-3):149-57. PubMed ID: 1684707 [TBL] [Abstract][Full Text] [Related]
26. [Relation of plasma glucose levels to serum lipids and apolipoproteins levels in middle and old age males]. Duan Y; Wu Z; Liu B Hua Xi Yi Ke Da Xue Xue Bao; 2001 Sep; 32(3):382-4. PubMed ID: 12536570 [TBL] [Abstract][Full Text] [Related]
27. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma. Cheung MC; Wolf AC; Illingworth DR Biochim Biophys Acta; 1992 Oct; 1128(2-3):244-9. PubMed ID: 1420297 [TBL] [Abstract][Full Text] [Related]
28. [Changes in the lipid profile in chronic hepatopathies]. Perales J; Angel Lasunción M; Cano A; Martín-Scapa MA; Matíes M; Herrera E Med Clin (Barc); 1994 Mar; 102(10):364-8. PubMed ID: 8182981 [TBL] [Abstract][Full Text] [Related]
29. In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency. Tilly-Kiesi M; Packard CJ; Kahri J; Ehnholm C; Shepherd J; Taskinen MR Atherosclerosis; 1997 Feb; 128(2):213-22. PubMed ID: 9050778 [TBL] [Abstract][Full Text] [Related]
30. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major. Al-Quobaili FA; Abou Asali IE Saudi Med J; 2004 Jul; 25(7):871-5. PubMed ID: 15235691 [TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein A1 gene polymorphisms and risk of early coronary disease. Reguero JR; Cubero GI; Batalla A; Alvarez V; Hevia S; Cortina A; Coto E Cardiology; 1998 Dec; 90(3):231-5. PubMed ID: 9892774 [TBL] [Abstract][Full Text] [Related]
32. Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B/A1 ratio in nonalcoholic steatohepatitis. Ozel Coskun BD; Yucesoy M; Gursoy S; Baskol M; Yurci A; Yagbasan A; Doğan S; Baskol G Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):142-9. PubMed ID: 25533429 [TBL] [Abstract][Full Text] [Related]
33. Short-term effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidemic healthy men. Taskinen MR; Kuusi T; Yki-Järvinen H; Nikkilä EA J Clin Endocrinol Metab; 1988 Aug; 67(2):291-9. PubMed ID: 3134387 [TBL] [Abstract][Full Text] [Related]
34. Apolipoproteins AI, AII and HDL phospholipids but not APO-B are risk indicators for occlusive cerebrovascular disease. Kostner GM; Marth E; Pfeiffer KP; Wege H Eur Neurol; 1986; 25(5):346-54. PubMed ID: 3096738 [TBL] [Abstract][Full Text] [Related]
36. Levels of serum lipids, apolipoproteins A-I and B and pseudocholinesterase activity and their discriminative values in patients with coronary by-pass operation. Lehtonen A; Marniemi J; Inberg M; Maatela J; Alanen E; Niittymäki K Atherosclerosis; 1986 Feb; 59(2):215-21. PubMed ID: 3083832 [TBL] [Abstract][Full Text] [Related]
37. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial. Hummel J; Westphal S; Weber-Hamann B; Gilles M; Lederbogen F; Angermeier T; Luley C; Deuschle M; Kopf D J Clin Psychiatry; 2011 Jul; 72(7):885-91. PubMed ID: 21294998 [TBL] [Abstract][Full Text] [Related]
38. Effects of L-carnitine supplementation on lipid profiles in patients with coronary artery disease. Lee BJ; Lin JS; Lin YC; Lin PT Lipids Health Dis; 2016 Jun; 15():107. PubMed ID: 27317162 [TBL] [Abstract][Full Text] [Related]